| 29.10.2025 07:00 | HEMO | Clinical Trial Update and Grant of Share Awards | RNS |
| 06.10.2025 14:22 | HEMO | Hemogenyx secures clearance for pediatric enrolment in leukemia trial | Alliance |
| 06.10.2025 07:00 | HEMO | Clearance to Initiate Pediatric Enrolment | RNS |
| 30.09.2025 13:11 | CPH2, TAND, GNIP | EARNINGS: Suspension damages Enwell Energy; forex hurts Hemogenyx | Alliance |
| 30.09.2025 07:00 | HEMO | Half-year Report | RNS |
| 30.09.2025 07:00 | HEMO | Total Voting Rights | RNS |
| 23.09.2025 15:51 | HEMO | Hemogenyx says exploring commercialisation of treatment for leukaemia | Alliance |
| 23.09.2025 07:00 | HEMO | Hemogenyx Signs Letter of Intent | RNS |
| 18.09.2025 13:16 | HEMO | Holding(s) in Company | RNS |
| 17.09.2025 11:54 | HEMO | Hemogenyx shares jump as third patient treated for leukaemia form | Alliance |
| 17.09.2025 07:00 | HEMO | Third Patient Safety | RNS |
| 11.09.2025 07:00 | HEMO | Invitation to Participate at DCNY Summit | Reach |
| 08.09.2025 16:27 | HEMO | Hemogenyx inks manufacturing partnership deal with Made Scientific | Alliance |
| 08.09.2025 07:00 | HEMO | Manufacturing Partnership with Made Scientific | RNS |
| 05.09.2025 07:00 | HEMO | Exercise of Warrants and Issue of Equity | RNS |
| 03.09.2025 13:57 | HEMO | Exercise of Warrants and Issue of Equity | RNS |
| 01.09.2025 15:06 | HEMO | Issue of convertible loan notes | RNS |
| 29.08.2025 07:00 | HEMO | Result of Audit Tender | RNS |
| 26.08.2025 13:54 | HEMO | Hemogenyx stock rises on GBP570,000 fundraise for Chimeric trials | Alliance |
| 26.08.2025 11:44 | HEMO | Hemogenyx raises £570,000 and Director's Dealing | RNS |
| 15.08.2025 12:34 | HEMO | Hemogenyx Pharmaceuticals shares up as phase one trial progresses | Alliance |
| 31.07.2025 07:00 | HEMO | Total Voting Rights | RNS |
| 29.07.2025 10:55 | SMWH, BIRG, HEMO | SMALL-CAP WINNERS & LOSERS: Card Factory buys WH Smith's funkypigeon | Alliance |
| 29.07.2025 08:00 | HEMO | Placing to Raise £250,000 and Director’s Dealing | RNS |
| 16.07.2025 14:34 | EEE, ENQ, EPP | TRADING UPDATES: Journeo, Physiomics and Synectics win contracts | Alliance |
| 16.07.2025 07:00 | HEMO | Hemogenyx Awarded Grant | RNS |
| 30.06.2025 07:00 | HEMO | Total Voting Rights | RNS |
| 17.06.2025 15:48 | RBW, CLA, HEMO | TRADING UPDATES: Safestay mulls asset sale; Sound Energy inks 2 deals | Alliance |
| 17.06.2025 07:00 | HEMO | Clearance to Proceed with Pediatric Expansion | RNS |
| 03.06.2025 22:11 | RENX, ARV, URU | TRADING UPDATES: Valereum invests in Blubird; Hemogenyx raises funds | Alliance |
| 03.06.2025 14:02 | HEMO | Placing to Raise £451,250 and Director’s Dealing | RNS |
| 03.06.2025 07:00 | HEMO | Second Patient Passes Initial Safety Tests | RNS |
| 30.05.2025 15:14 | HEMO | Total Voting Rights | RNS |
| 29.05.2025 14:06 | HEMO | Result of AGM | RNS |
| 22.05.2025 14:05 | PYX, TPFG, KAV | UK shareholder meetings calendar - next 7 days | Alliance |
| 14.05.2025 14:28 | HEMO | IN BRIEF: Hemogenyx expands trial to include paediatric patients | Alliance |
| 14.05.2025 07:00 | HEMO | Pediatric Amendment to Clinical Protocol | Reach |
| 13.05.2025 07:00 | HEMO | AGM Correction | RNS |
| 08.05.2025 07:00 | HEMO | Placing to Raise £451,250 and Director’s Dealing | RNS |
| 02.05.2025 22:05 | GCL, VRS, ARS | TRADING UPDATES: GlobalData suspends buyback; Hemogenyx trial progress | Alliance |
| 02.05.2025 16:24 | HEMO | Notice of AGM | RNS |
| 02.05.2025 07:00 | HEMO | Second Patient Treated with HG-CT-1 CAR-T Therapy | RNS |
| 28.04.2025 07:00 | HEMO | Final Results | RNS |
| 04.04.2025 19:24 | ARV, GCG, ESO | TRADING UPDATES: Golden Rock secures refinancing; tinyBuild makes sale | Alliance |
| 03.04.2025 07:00 | HEMO | FDA Annual Report | Reach |
| 31.03.2025 07:00 | HEMO | Total Voting Rights | RNS |
| 17.03.2025 07:00 | HEMO | Recruitment of Second Patient for Clinical Trials | RNS |
| 13.03.2025 15:10 | HEMO | Conversion of convertible loan notes | RNS |
| 11.03.2025 07:00 | HEMO | Institutional investment | RNS |
| 24.02.2025 11:06 | HEMO | IN BRIEF: Hemogenyx administers first human dose for leukemia therapy | Alliance |
| 24.02.2025 07:00 | HEMO | First-in-Human Treatment with HG-CT-1 | RNS |
| 19.02.2025 16:50 | HEMO | Issue of convertible loan notes | RNS |
| 31.01.2025 09:35 | HEMO | Total Voting Rights | RNS |
| 08.01.2025 11:49 | HEMO | IN BRIEF: Hemogenyx Pharmaceuticals raises GBP340,000 for drug trial | Alliance |
| 08.01.2025 07:00 | HEMO | Placing to raise £340,000 | RNS |
| 02.01.2025 07:00 | HEMO | Change of Company Secretary and Registered Office | RNS |
| 31.12.2024 07:00 | HEMO | Total Voting Rights | RNS |
| 30.12.2024 12:01 | HEMO | Hemogenyx opens first clinical site for leukaemia therapy trial | Alliance |
| 30.12.2024 07:00 | HEMO | Opening of First Clinical Site | RNS |
| 19.12.2024 07:00 | HEMO | Ultrafast CAR-T Manufacturing | RNS |
| 06.12.2024 15:40 | HEMO | TRADING UPDATES: SDX plots AIM exit; Celadon receives funds | Alliance |
| 06.12.2024 07:00 | HEMO | CBR Macrophage Delivery Update | RNS |
| 02.12.2024 13:32 | SCT, POS, NTVO | UK shareholder meetings calendar - next 7 days | Alliance |
| 29.11.2024 07:00 | HEMO | Total Voting Rights | RNS |
| 22.11.2024 12:49 | HEMO | Notice of Extraordinary General Meeting | RNS |
| 22.11.2024 07:00 | HEMO | IRB Approval for Phase I Clinical Trial | RNS |
| 11.11.2024 07:00 | HEMO | Institutional Investment | RNS |
| 30.10.2024 11:09 | HEMO | IN BRIEF: Hemogenyx to launch myeloid leukemia treatment phase 1 trial | Alliance |
| 30.10.2024 07:00 | HEMO | Schedule for Phase I Clinical Trial Opening | RNS |
| 02.10.2024 11:19 | HEMO | Strategic Investment from Prevail Partners, LLC | RNS |
| 27.09.2024 18:25 | HEMO | Hemogenyx Pharmaceuticals loss narrows amid reduced expenses | Alliance |
| 27.09.2024 15:55 | HEMO, EUA, MFAI | EARNINGS: Clean Power Hydrogen loss widens; Invinity loss narrows | Alliance |
| 27.09.2024 07:00 | HEMO | Half-year Report | RNS |
| 09.09.2024 22:03 | PANR, UKOG, CIZ | TRADING UPDATES: Light Science Technologies wins two new contracts | Alliance |
| 09.09.2024 07:00 | HEMO | FLT3 Assay Ready for Phase I Trials at MD Anderson | RNS |
